These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16007343

  • 1. Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production.
    Yip KH, Zheng MH, Steer JH, Giardina TM, Han R, Lo SZ, Bakker AJ, Cassady AI, Joyce DA, Xu J.
    J Bone Miner Res; 2005 Aug; 20(8):1462-71. PubMed ID: 16007343
    [Abstract] [Full Text] [Related]

  • 2. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J.
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [Abstract] [Full Text] [Related]

  • 3. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
    Wu X, Pan G, McKenna MA, Zayzafoon M, Xiong WC, McDonald JM.
    J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
    Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M.
    J Cell Biochem; 2004 May 15; 92(2):285-95. PubMed ID: 15108355
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.
    J Bone Miner Res; 2005 Apr 15; 20(4):653-62. PubMed ID: 15765185
    [Abstract] [Full Text] [Related]

  • 10. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 11. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F, Matsubara T, Tsurukai T, Hata K, Nishimura R, Yoneda T.
    J Bone Miner Res; 2008 Jun 01; 23(6):907-14. PubMed ID: 18251700
    [Abstract] [Full Text] [Related]

  • 12. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 01; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 13. Reactive oxygen species mediate RANK signaling in osteoclasts.
    Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH.
    Exp Cell Res; 2004 Dec 10; 301(2):119-27. PubMed ID: 15530848
    [Abstract] [Full Text] [Related]

  • 14. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
    Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L.
    J Bone Miner Res; 2004 Feb 10; 19(2):207-13. PubMed ID: 14969390
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 10; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 17. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.
    Aitken CJ, Hodge JM, Nishinaka Y, Vaughan T, Yodoi J, Day CJ, Morrison NA, Nicholson GC.
    J Bone Miner Res; 2004 Dec 10; 19(12):2057-64. PubMed ID: 15537450
    [Abstract] [Full Text] [Related]

  • 18. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627
    [Abstract] [Full Text] [Related]

  • 19. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H, Murakami A, Aggarwal BB.
    Mol Cancer Res; 2006 Apr 17; 4(4):275-81. PubMed ID: 16603641
    [Abstract] [Full Text] [Related]

  • 20. Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-kappaB and AP-1 and also reduced osteoclast activity and survival.
    Hwang YH, Lee JW, Hahm ER, Jung KC, Lee JH, Park CH, Rhee HS, Ryu JM, Kim HK, Yang CH.
    Biochem Biophys Res Commun; 2005 Nov 25; 337(3):815-23. PubMed ID: 16213465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.